Bio-Rad Laboratories, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BIO-B | BRKR | 1302.HK | NEOG | LAB | 49Z.F | |
|---|---|---|---|---|---|---|
| Market cap | 10.15B | 9.72B | 7.20B | 2.72B | 243.19M | 154.56M |
| P/E (TTM) | 48.1 | — | 163.5 | — | — | — |
| Forward P/E | — | 26.5 | — | 27.7 | -61.6 | — |
| Price/book | 1.4 | 4.2 | 1.9 | 1.3 | 0.4 | 0.1 |
| Dividend yield | — | 0.31% | — | — | — | — |
| 1-year change | +24.26% | +62.27% | −13.09% | +108.36% | −44.64% | +7.89% |
| Today | 0.00% | +12.90% | −1.51% | +2.98% | +0.85% | +3.30% |
The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.
Latest news
All BIO-B news ›Head to Head Comparison: Bio-Rad Laboratories (NYSE:BIO) versus Medpace (NASDAQ:MEDP)
Posted by Sarita Garza on Oct 20th, 2026 Medpace (NASDAQ:MEDP – Get Free Report) and Bio-Rad Laboratories (NYSE:BIO – Get Free Report) are both healthcare companies, but which is the superior investment? We will compare the two companies…
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Recommendation of “Hold” from Brokerages
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been assigned a consensus recommendation of “Hold” from the five brokerages that are currently covering the company, MarketBeat reports. Four research analysts have rated the…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- themarketsdaily.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.